![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Motzer, Robert J.; Martini, Jean-Francois; Mu, Xinmeng J.; Staehler, Michael; George, Daniel J.; Valota, Olga; Lin, Xun; Pandha, Hardev S.; Ching, Keith A. und Ravaud, Alain
(2022):
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial.
In: Nature Communications, Bd. 13, Nr. 1, 5959
George, Daniel J.; Martini, Jean-Francois; Staehler, Michael; Motzer, Robert J.; Magheli, Ahmed; Donskov, Frede; Escudier, Bernard; Li, Sherry; Casey, Michelle; Valota, Olga; Laguerre, Brigitte; Pantuck, Allan J.; Pandha, Hardev S.; Patel, Anup; Lechuga, Maria und Ravaud, Alain
(2019):
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.
In: Clinical Cancer Research, Bd. 25, Nr. 4: S. 1165-1173
Motzer, Robert J.; Ravaud, Alain; Patard, Jean-Jacques; Pandha, Hardev S.; George, Daniel J.; Patel, Anup; Chang, Yen-Hwa; Escudier, Bernard; Donskov, Frede; Magheli, Ahmed; Carteni, Giacomo; Laguerre, Brigitte; Tomczak, Piotr; Breza, Jan; Gerletti, Paola; Lechuga, Mariajose; Lin, Xun; Casey, Michelle; Serfass, Lucile; Pantuck, Allan J. und Stähler, Michael
(2018):
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.
In: European Urology, Bd. 73, Nr. 1: S. 62-68